|
Orthologous residues
|
|
vimentin (human): S55‑p, vimentin (mouse): S55‑p, vimentin (rat): S55‑p, vimentin (hamster): S54‑p, vimentin (cow): S55‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Disease tissue studied:
leukemia, chronic lymphocytic leukemia
|
|
Relevant cell lines - cell types - tissues:
L1210 (lymphoblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
roscovitine
|
|
|
|
decrease
|
|
|
